TABLE 2.

Cardiometabolic markers and NCD prevalence in the 2 groups¹

	Exposed			Unexposed
	n (total)	%	Mean ± SD	n (total)	%	Mean ± SD	P value
Anthropometry
Weight, kg	509		53.5 ± 7.9	396		55.1 ± 7.2	<0.001
Height, cm	520		155.9 ± 8.9	406		157.6 ± 8.9	0.002
BMI	509		22.0 ± 2.9	396		22.2 ± 2.5	0.24
Thinness		7.7			3.8		0.049
Normal		79.4			83.3
Overweight		13.0			12.9
Waist circumference, cm	519		79.1 ± 9.2	406		77.9 ± 8.3	0.046
Hip circumference, cm	517		84.5 ± 8.6	405		86.0 ± 7.7	0.005
Waist-to-hip ratio	516		0.94 ± 0.12	405		0.91 ± 0.11	<0.001
Waist-to-height ratio	519		0.51 ± 0.06	406		0.50 ± 0.06	0.001
Muscle strength, kg	385		29.9 ± 8.6	303		32.8 ± 8.8	<0.001
BP, mm Hg
Systolic BP	358		121.1 ± 13.5		269	121.8 ± 12.9	0.54
Diastolic BP	386		70.9 ± 10.7			71.6 ± 10.1	0.37
Mean BP	358		95.8 ± 10.3			96.7 ± 9.8	0.29
Glucose
Fasting glycemia, mg/dL	398		105.1 ± 16.5	319		103.7 ± 14.5	0.23
HbA1c, %	58		4.6 ± 0.6	52		4.2 ± 0.3	<0.001
Lipid profile, mg/dL
Total cholesterol	424		154.2 ± 35.5	331		159.1 ± 36.6	0.062
HDL-C	424		43.8 ± 8.5	331		44.4 ± 8.4	0.37
LDL-C	412		90.1 ± 30.5	319		94.2 ± 31.2	0.08
TG	412		97.8 (74.7, 128.4)2	322		97.2 (74.7, 126.4)2	0.72
Creatinine, mg/dL	421		0.87 ± 0.17	331		0.88 ± 0.19	0.55
Albumin, mg/dL	424		4.38 ± 0.34	328		4.44 ± 0.31	0.020
Cardiovascular risk factors
1. Alcohol (yes)	524	35.9		407	40.3		0.17
2. Tobacco (yes)	524	3.1		407	1.5		0.12
3. Parent with HTA and/or DM	524	32.3		407	32.9		0.83
4. Dyslipidemia
High LDL-C	412	2.4		319	1.6		0.42
low HDL-C	424	38.4		331	34.1		0.22
5. DM	398	9.6		319	7.5		0.34
6. HTA	384	6.5		299	6.4		0.93
7. Visceral obesity	492	52.4		372	43.8		0.012
8. Metabolic syndrome	332	10.8		265	4.9		0.009
1. Central obesity	517	6.4		405	4.4
2. Fasting hyperglycemia	398	32.4		319	25.4
3. Low HDL-C	424	58.5		331	55.6
4. High TG	412	8.7		322	7.1
5. HTA or anti-hypertensive therapy	384	19.0		299	18.4

¹BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated hemoglobin; HTA, hypertension; NCD, noncommunicable diseases; TG, triglyceride.

²Geometric mean ± SD.